期刊文献+

2型糖尿病合并脂代谢紊乱与血压、肥胖、并发症相关性的研究 被引量:9

The study on the relationship with BP,obesity and diabetic complications
下载PDF
导出
摘要 目的:探讨2型糖尿病合并脂代谢紊乱与血压、肥胖、并发症的关系。方法:将155例2型糖尿病患者,按有无血脂异常分为高脂血症组和非高脂血症组,测定TG、LDL-C、HDL-C、TC、FPG、HbA1c、BP,计算BMI并进行统计学分析。结果:高脂血症组与非高脂血症组在收缩压、舒张压、BMI、载脂蛋白B(ApoB)等方面比较,差异有统计学意义(P均<0.05)。在糖尿病肾病、糖尿病视网膜病变并发症方面,差异有统计学意义(P<0.05)。结论:2型糖尿病合并脂代谢紊乱与血压、肥胖及糖尿病肾病、糖尿病视网膜病变有关。 Objective:To investigate the correlation between the type 2 diabetes mellitus with dyslipidemia and the blood pressure,obesity and diabetic complication. Methods:The patients(n=155) with type 2 diabetes mellitus were divided into the group of hyperlipoidemia and the group of non-hyperlipoidemia according to blood liquid. The levels of TG,LDL-C,HDL-C,TC,FPG,HbA1c and BP were detected in two groups respectively. The BMI were calculated and statist analyse method was adopted. Results:There was significantly different in the systolic,diastolic pressure,BMI,ApoB,and the com-plications of diabetic nephropathy,diabetic retinopathy between the two group(P〈0.05). Conclusion:The type 2 diabetes mellitus with dyslipidemia have relationship with BP,obesity and diabetic complications.
出处 《中国当代医药》 2010年第23期7-8,15,共3页 China Modern Medicine
基金 北京中医药大学中青年教师资助项目
关键词 2型糖尿病 脂代谢紊乱 血压 肥胖 并发症 Type 2 diabetes mellitus Dyslipidemia The blood pressure Obesity and diabetic complication
  • 相关文献

参考文献5

二级参考文献16

共引文献78

同被引文献50

  • 1李娜,胡婕.瑞格列奈和格列吡嗪治疗肥胖及非肥胖2型糖尿病的临床比较[J].中国药物与临床,2006,6(1):71-71. 被引量:4
  • 2崔兰,金平锡,金永哲,方今女.朝鲜族和汉族居民不同类型高血压患病现况调查[J].延边大学医学学报,2006,29(3):190-194. 被引量:11
  • 3梁学军,侯冬青,巩纯秀,曹冰燕,颜纯.超体质量、肥胖及黑棘皮病与空腹指血血糖相关性调查[J].首都医科大学学报,2007,28(3):292-295. 被引量:8
  • 4Shepherd JT. Franz Volhard lecture: Increased systemic vascular resistance and primary hypertension: the expanding complexity[ J]. J Hypertens Suppl, 1990,8 :S15 - S27.
  • 5Van De Water JM, Miller TW, Vogel RL, et al. Imped- ance cardiography; The next vital sign technology? [ J ]. Chest, 2003,123 : 2028 - 2033.
  • 6Zambare S,Samantray J,Seyoum B,et al.Glucose control andlipid metabolism in African American patients with type 2 diabetesand chronic hepatitis C[J].Endocr Pract,2010,6:1-19.
  • 7Wolf G.Role of fatty acids in the development of insulin resistanceand type 2 diabetes mellitus[J].Nutr Rev,2008,66(10):597-600.
  • 8Perkins WJ Jr.Combination lipid therapy in type 2 diabetes.NewEngland Journal of Medicine[J].2010,362(17):1563-1574.
  • 9Cummings BP,Strader AD,Stanhope KL,et al.Ilealinterposition surgery improves glucose and lipid metabolism anddelays diabetes onset in the UCD-T2DM rat[J].Gastroenterology,2010,138(7):2224-2226.
  • 10Andallu B,Vinay Kumar AV,Varadacharyulu NCh.Lipidabnormalities in streptozotocin-diabetes:Amelioration by Morusindica L.cv Suguna leaves[J].Int J Diabetes Dev Ctries,2009,29(3):123-128.

引证文献9

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部